Who Paid My Doc
A Phase 1 Sad MD in Diabetic MacUlar Edema
Research payments
$7,903,167
Through program year 2025, $7,903,167 in research payments was reported against A Phase 1 Sad MD in Diabetic MacUlar Edema, across 1,024 payments, paid by Genentech, Inc..
- Paid by
- Genentech, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $2,980,177 | 279 |
| 2024 | Research | $3,004,225 | 452 |
| 2023 | Research | $1,615,880 | 224 |
| 2022 | Research | $302,885 | 69 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Brian Berger Austin, TX Named on 88 payments
- Stephen Huddleston Germantown, TN Named on 65 payments
- Sunil Patel Abilene, TX Named on 49 payments
- Seong Lee Abilene, TX Named on 44 payments
- Allen Hu Los Angeles, CA Named on 34 payments
- John Wells West Columbia, SC Named on 27 payments
- Katrina Mears Detroit, MI Named on 24 payments
- Richard Lane Goldsboro, NC Named on 24 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.